New Antiretroviral Treatment for HIV
| Autor: | Mark Biagi, John A. Littler, Sarah E. Pérez, Melissa E Badowski |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Gerontology business.industry Transmission (medicine) Human immunodeficiency virus (HIV) Antiretrovirals Review medicine.disease medicine.disease_cause 030112 virology 03 medical and health sciences Infectious Diseases Quality of life (healthcare) Acquired immunodeficiency syndrome (AIDS) HIV/AIDS treatment Pill Immunology Antiretroviral treatment Life expectancy Medicine HIV/AIDS Viral suppression HIV pipeline business |
| Zdroj: | Infectious Diseases and Therapy |
| ISSN: | 2193-8229 |
| Popis: | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set the global goal of ending the AIDS world epidemic by 2030. In order to end this epidemic they have established a 90-90-90 goal to be achieved by 2020, which may be problematic, especially in low- and middle-income countries. This goal includes 90% of individuals with HIV globally being diagnosed, on treatment, and virologically suppressed. Based on global estimates from 2014–2015, approximately 36.9 million individuals are living with HIV. Of those, 53% have been diagnosed with HIV, 41% are on antiretroviral therapy (ART), and 32% have viral suppression with |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|